Emerging Roles of IL-33/ST2 Axis in Renal Diseases
AbstractRenal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), have a great impact on health care systems worldwide. Similar to cardiovascular diseases, renal diseases are inflammatory diseases involving a variety of cytokines. Primary causes of renal injury include ischemia, uremic toxins, bacteremia, or nephrotoxicity. Inflammation represents an important component following kidney injury. Interleukin (IL)-33 is a member of the IL-1 cytokine family, which is widely expressed in epithelial barrier tissues and endothelial cells, and mediates both tissue inflammation and repair responses. IL-33 is released as a nuclear alarmin in response to tissue damage and triggers innate and adaptive immune responses by binding to its receptor, suppression of tumorigenicity 2 (ST2). Recent evidence from clinical and experimental animal studies indicates that the IL-33/ST2 axis is involved in the pathogenesis of CKD, renal graft injury, systemic lupus nephritis, and AKI. In this review, we discuss the pathological and tissue reparative roles of the IL-33/ST2 pathway in different types of renal diseases. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Chen, W.-Y.; Li, L.-C.; Yang, J.-L. Emerging Roles of IL-33/ST2 Axis in Renal Diseases. Int. J. Mol. Sci. 2017, 18, 783.
Chen W-Y, Li L-C, Yang J-L. Emerging Roles of IL-33/ST2 Axis in Renal Diseases. International Journal of Molecular Sciences. 2017; 18(4):783.Chicago/Turabian Style
Chen, Wei-Yu; Li, Lung-Chih; Yang, Jenq-Lin. 2017. "Emerging Roles of IL-33/ST2 Axis in Renal Diseases." Int. J. Mol. Sci. 18, no. 4: 783.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.